A panel of medical experts provide insights on the treatment landscape of Multidrug-Resistant HIV.
February 23rd 2023EP. 1: Incidence and Prevalence of MDR HIV
Ryan Haumschild, PharmD, MS, MBA, opens a panel discussion surrounding the incidence and prevalence of multidrug-resistant (MDR) HIV.
February 23rd 2023EP. 2: Resistance Mechanisms Leading to MDR HIV
Michael Sension, MD, provides insights on resistance mechanisms promoting MDR HIV.
March 2nd 2023EP. 3: Economic and Social Burdens Associated with MDR HIV
A panel of experts explore burdens impacting patients diagnosed with MDR HIV.
March 2nd 2023EP. 4: Social Determinants of Health Impacting Patients Diagnosed with MDR HIV
Dr Haumschild leads a discussion highlighting goals of therapy and social determinants of health affecting MDR HIV diagnosis and treatment.
March 8th 2023EP. 5: Pharmacotherapeutic Treatment Options for Treating MDR HIV
Optimized background regimens are highlighted in the treatment approach for MDR HIV by Michael Sension, MD.
March 8th 2023EP. 6: MDR HIV Treatment Approaches and Considerations for Therapeutic Adjustments
Therapy adjustments in MDR HIV are explored by Dr Sension.
March 15th 2023EP. 7: Patient and Payer Considerations for Medication Regimen Adherence In MDR HIV Treatment Pathway
The panel discusses considerations for payers as well as patient adherence to treatment in MDR HIV.
March 15th 2023EP. 8: Considerations with Non-Adherence to Standard Background MDR HIV Therapy
Key opinion leaders highlight barriers to MDR HIV treatment adherence.
March 22nd 2023EP. 9: Payers and Clinicians Impacted by CD4 Recovery
Dr Sension underlines the value of CD4 recovery from payer and clinician perspectives.
March 22nd 2023EP. 10: Medication Burden and Stigma Impacting Adherence Rates in Patients With MDR HIV
Daniel Driffin, BS, MPH, provides insights regarding factors influencing patient adherence to multidrug-resistant HIV treatment.
March 29th 2023EP. 11: Cost of Care Implications for Treated Versus Non-Treated MDR HIV
Maria Lopes, MD, MS, and Mr Driffin explore total cost of care affected by various multidrug-resistant treatment regimens.
March 29th 2023EP. 12: Optimal Treatment of MDR HIV Impacting Population Health
Dr Lopes and Mr Driffin discuss cost considerations and utilization barriers inhibiting treatment for patients with multidrug-resistant HIV.
March 29th 2023EP. 13: Final Overview of MDR HIV Treatment Landscape
Panelists provide their closing thoughts on the disease state and treatment landscape of multidrug-resistant HIV.
